Literature DB >> 3515657

Cyclosporine-associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury.

J A Walfe, R L McCann, F Sanfilippo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515657

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

Authors:  D Hébert; E M Kim; R K Sibley; M S Mauer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

3.  Arteriolosclerosis of the human renal allograft: morphology, origin, life history and relationship to cyclosporine therapy.

Authors:  P Rossmann; J Jirka; M Chadimová; I Reneltová; F Saudek
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Cyclosporine-associated microangiopathic hemolytic anemia in a renal transplant recipient.

Authors:  N Yoshimura; T Oka; Y Ohmori; I Aikawa; T Yasumura; S Matsui; T Hamashima; C J Lee
Journal:  Jpn J Surg       Date:  1989-03

5.  Hemolytic uremic syndrome: new developments in pathogenesis and treatment.

Authors:  Olivia Boyer; Patrick Niaudet
Journal:  Int J Nephrol       Date:  2011-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.